Results 11 to 20 of about 13,822,676 (240)

On the Integration of Pharmacophore Model and Molecular Docking Method

open access: yesJournal of Algorithms & Computational Technology, 2011
Structure-based molecular docking has been recognized as the most effective virtual screening technology. Two aspects decide the accuracy of virtual screening result: one is the simulation degree to the interaction of ligands and acceptors, the other is ...
G. Dong, X.J. Deng, J.H. Xiao
doaj   +2 more sources

A Selective Pharmacophore Model for β2-Adrenoceptor Agonists

open access: yesMolecules, 2009
β2-Adrenoceptor selectivity is an important consideration in drug design in order to minimize the possibility of side effects. A selective pharmacophore model was developed based on a series of selective β2-adrenoceptor agonists.
Mao-Sheng Cheng   +3 more
doaj   +2 more sources

Development and validation of a 3D similarity method for virtual screening [PDF]

open access: yes, 2013
A predictive 3D similarity workflow approach has been developed using a set of modular Java computer programs that implement algorithms that aim to capture the key components of a 3D similarity search and aim to incorporate methods that address both ...
Butler, Daniel
core   +6 more sources

Pharmacophore-based ML model to predict ligand selectivity for E3 ligase binders [PDF]

open access: yes, 2023
E3 ligases are enzymes that play a critical role in ubiquitin-mediated protein degradation and are involved in various cellular processes. Pharmacophore analysis is a useful approach for predicting E3 ligase binding selectivity, which involves ...
Andrea, Zaliani   +3 more
core   +2 more sources

Design of dual ligands using excessive pharmacophore query alignment : from 7th German Conference on Chemoinformatics: 25 CIC-Workshop Goslar, Germany, 6 - 8 November 2011 [PDF]

open access: yes, 2012
Dual- or multi-target ligands have gained increased attention in the past years due to several advantages, including more simple pharmacokinetic and phamarcodynamic properties compared to a combined application of several drugs.
Achenbach Janosch   +26 more
core   +1 more source

Pharmacophore mapping: Prediction of BCR–ABL kinase inhibitory activity of α-benzylthio chalcones

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2014
In this investigation, 3D pharmacophore modeling studies were performed on a diverse set of 33 α-benzylthio chalcone derivatives that demonstrate anticancer activity by blocking BCR–ABL phosphorylation in leukemic cells.
Richa Bajaj, Vikas Sharma, Vipin Kumar
doaj   +1 more source

Pharmacophore mapping studies on indolizine derivatives as 15-LOX inhibitors

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2015
This investigation analyzes the common chemical features for 15-lipoxygenase (15-LOX) inhibitors to develop ligand-based pharmacophore models for lipoxygenase inhibitory activity.
Vikas Sharma, Vipin Kumar
doaj   +1 more source

Identification of novel HIV 1--protease inhibitors: application of ligand and structure based pharmacophore mapping and virtual screening. [PDF]

open access: yesPLoS ONE, 2012
A combined ligand and structure-based drug design approach provides a synergistic advantage over either methods performed individually. Present work bestows a good assembly of ligand and structure-based pharmacophore generation concept.
Divya Yadav   +4 more
doaj   +1 more source

LSD1-Based Reversible Inhibitors Virtual Screening and Binding Mechanism Computational Study

open access: yesMolecules, 2023
As one of the crucial targets of epigenetics, histone lysine-specific demethylase 1 (LSD1) is significant in the occurrence and development of various tumors.
Zhili Yin   +6 more
doaj   +1 more source

Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning

open access: yesMolecules, 2020
A significant percentage of Duchenne muscular dystrophy (DMD) cases are caused by premature termination codon (PTC) mutations in the dystrophin gene, leading to the production of a truncated, non-functional dystrophin polypeptide.
Kate Wang   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy